首頁 > 市場調查報告書 > 製藥

非專利藥

市場調查報告書

商品編碼

1542618

全球品牌學名藥市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Branded Generics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球品牌學名藥市場需求預計將從 2023 年的 2,893.1 億美元達到近 5,022.3 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.32%。

品牌學名藥是指已提供市場名稱的學名藥。它們的行銷方式通常類似於品牌藥物。相比之下，普通學名藥通常透過其化學名稱而為人所知。然而，品牌學名藥具有優勢，因為它們可以提高消費者忠誠度並提高認可度。一些品牌學名藥也專門作為非專利藥物的新劑型製造。填補劑量空白，同時為消費者提供比真正的通用名稱更容易記住的名稱，是品牌學名藥最顯著的優勢。

市場動態

品牌學名藥具有多種優勢，包括製造商能夠獲得知名度以及比普通學名藥更高的成本。它們是品牌藥物的更便宜的替代品，並且通常致力於節省成本。此外，由於功效、值得信賴的品質和差異化的產品，該產品正在慢慢受到歡迎。它們在中國、印度、智利等低收入和中等收入國家也顯示出成長，目前被認為是整個學名藥市場的一個小但有利可圖的子集。然而，需要注意的是，如果它們不共同配製，較高的藥物負擔可能會阻礙依從性。此外，該產品的問題在於，如果生產藥物的藥房也會發生變化，它們的外觀有時也會改變。這可能會讓消費者感到困惑。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球品牌學名藥市場的每個細分市場進行了包容性評估。品牌學名藥產業的成長和趨勢為本研究提供了整體方法。

市場區隔

品牌學名藥市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥物類別

烷基化劑
抗代謝藥
荷爾蒙
抗高血壓
降血脂藥
抗憂鬱藥
抗精神病藥
抗癲癇藥
其他

按申請

腫瘤學
心血管疾病
神經系統疾病
胃腸道疾病
皮膚科疾病
急性和慢性疼痛
其他

按主題

口服
注射用
其他

按配銷通路

醫院藥房
零售藥房
網路藥房

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲品牌學名藥市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。品牌學名藥市場的主要參與者包括Teva Pharmaceutical Industries Ltd.、Lupin、Sanofi、Sun Pharmaceutical Industries Ltd.、Dr. Reddy'S Laboratories Ltd.、Endo International Plc、GlaxoSmithKline Plc、Pfizer Inc.、Apotex Inc.、Viatris Inc. 。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按藥品類別分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按主題進行的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球品牌學名藥市場分析：按藥品類別

按藥物類別概述
按藥物類別進行歷史和預測數據分析
烷基化劑
抗代謝藥
荷爾蒙
抗高血壓
降血脂藥
抗憂鬱藥
抗精神病藥
抗癲癇藥
其他

第 6 章：全球品牌學名藥市場分析：按應用分類

概述：按應用
歷史與預測資料分析：按應用分類
腫瘤學
心血管疾病
神經系統疾病
胃腸道疾病
皮膚科疾病
急性和慢性疼痛
其他

第 7 章：全球品牌學名藥市場分析：依主題分類

按主題概述
按主題進行的歷史和預測資料分析
口服
注射用
其他

第 8 章：全球品牌學名藥市場分析：按分銷管道

配銷通路概覽
按配銷通路進行歷史和預測資料分析
醫院藥房
零售藥房
網路藥房

第 9 章：全球品牌學名藥市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：品牌學名藥公司的競爭格局

品牌學名藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Lupin

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Sun Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Dr. Reddy'S Laboratories Ltd.

公司概況
公司收入
產品
最新動態

Endo International Plc

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Apotex Inc.

公司概況
公司收入
產品
最新動態

Viatris Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216173

The global demand for Branded Generics Market is presumed to reach the market size of nearly USD 502.23 Billion by 2032 from USD 289.31 Billion in 2023 with a CAGR of 6.32% under the study period 2024-2032.

Branded generics refer to generic drugs that have been provided with a market name. They are generally marketed akin to the way branded drugs are. In comparison, ordinary generic drugs are usually known by their chemical names. However, branded generics are advantageous as they promote consumer loyalty and drive recognition. Some branded generics are also made particularly as novel dosage forms of off-patent drugs. Filling in a dosage gap while simultaneously providing consumers a name that is easy to remember than the true generic name is the most significant advantage of branded generics.

MARKET DYNAMICS

Branded generics have several advantages, including manufacturers' ability to get name recognition and higher costs than ordinary generics. They are a cheaper alternative to branded drugs and often work towards releasing savings. Further, the product is slowly gaining popularity due to efficacy, trusted quality, and differentiated products. They are showing growth in low-and middle-income countries like China, India, Chile, etc. as well and are currently considered a small but profitable subset of the whole generic market. However, it needs to be noted that if they are not co-formulated, higher pill burdens may discourage adherence. Further, the problem with the product is that their appearance can at times change if the pharmacy producing the medicine changes as well. This can confuse consumers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Branded Generics. The growth and trends of Branded Generics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Branded Generics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Others

By Application

Oncology
Cardiovascular Diseases
Neurological Diseases
Gastrointestinal Diseases
Dermatological Diseases
Acute And Chronic Pain
Others

By Topical

Oral
Parenteral
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Branded Generics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Branded Generics market include Teva Pharmaceutical Industries Ltd., Lupin, Sanofi, Sun Pharmaceutical Industries Ltd., Dr. Reddy'S Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Pfizer Inc., Apotex Inc., Viatris Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BRANDED GENERICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Topical
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRANDED GENERICS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data Analysis By Drug Class
5.3. Alkylating Agents Historic and Forecast Sales By Regions
5.4. Antimetabolites Historic and Forecast Sales By Regions
5.5. Hormones Historic and Forecast Sales By Regions
5.6. Anti-Hypertensive Historic and Forecast Sales By Regions
5.7. Lipid Lowering Drugs Historic and Forecast Sales By Regions
5.8. Anti-Depressants Historic and Forecast Sales By Regions
5.9. Anti-Psychotics Historic and Forecast Sales By Regions
5.10. Anti-Epileptics Historic and Forecast Sales By Regions
5.11. Others Historic and Forecast Sales By Regions

6. GLOBAL BRANDED GENERICS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Oncology Historic and Forecast Sales By Regions
6.4. Cardiovascular Diseases Historic and Forecast Sales By Regions
6.5. Neurological Diseases Historic and Forecast Sales By Regions
6.6. Gastrointestinal Diseases Historic and Forecast Sales By Regions
6.7. Dermatological Diseases Historic and Forecast Sales By Regions
6.8. Acute And Chronic Pain Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL BRANDED GENERICS MARKET ANALYSIS BY TOPICAL

7.1. Overview By Topical
7.2. Historical and Forecast Data Analysis By Topical
7.3. Oral Historic and Forecast Sales By Regions
7.4. Parenteral Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL BRANDED GENERICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data Analysis By Distribution Channel
8.3. Hospital Pharmacy Historic and Forecast Sales By Regions
8.4. Retail Pharmacy Historic and Forecast Sales By Regions
8.5. Online Pharmacy Historic and Forecast Sales By Regions

9. GLOBAL BRANDED GENERICS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BRANDED GENERICS COMPANIES

10.1. Branded Generics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF BRANDED GENERICS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Teva Pharmaceutical Industries Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Lupin
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Sanofi
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Sun Pharmaceutical Industries Ltd.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Dr. Reddy'S Laboratories Ltd.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Endo International Plc
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. GlaxoSmithKline Plc
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Pfizer Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Apotex Inc.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Viatris Inc
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments